Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry
Mazieres, J., Drilon, A., Lusque, A., Mhanna, L., Cortot, A.B., Mezquita, L., Thai, A.A., Mascaux, C., Couraud, S., Veillon, R., Van den Heuvel, M., Neal, J., Peled, N., Früh, M., Ng, T.L., Gounant, V., Popat, S., Diebold, J., Sabari, J., Zhu, V.W., Rothschild, S.I., Bironzo, P., Martinez-Marti, A., Curioni-Fontecedro, A., Rosell, R., Lattuca-Truc, M., Wiesweg, M., Besse, B., Solomon, B., Barlesi, F., Schouten, R.D., Wakelee, H., Camidge, D.R., Zalcman, G., Novello, S., Ou, S.I., Milia, J., Gautschi, O.
Published in Annals of oncology (01.08.2019)
Published in Annals of oncology (01.08.2019)
Get full text
Journal Article
942P Response to salvage chemotherapy with paclitaxel +/- cetuximab after progression on immune checkpoint inhibitors in platinum-refractory recurrent and/or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN) patients (CeTax study)
Herrera Gomez, R.G., Saleh, K., Auclin, E., Vinches, M., Gervais, C., Espeli, V.G., Rothschild, S.I., Even, C., Cristina, V.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
95P Role of postoperative follow-up with 18F-FDG PET/CT in asymptomatic NSCLC patients: A retrospective single institution study
Kaumanns, A., König, D., Hojski, A., Cattaneo, M., Chirindel, A-F., Tamm, M., Lardinois, D., Rothschild, S.I.
Published in Annals of oncology (01.04.2022)
Published in Annals of oncology (01.04.2022)
Get full text
Journal Article
4P Prevalence of MET exon 14-mutations or MET amplification in non-small cell lung cancer in Swiss patients
Prince, S. Savic, Bihl, M., Eppenberger-Castori, S., Matter, M.S., Zellweger, N., Rothschild, S.I., Bubendorf, L.
Published in Journal of thoracic oncology (01.04.2021)
Published in Journal of thoracic oncology (01.04.2021)
Get full text
Journal Article
1336P Small cell transformation in EGFR-mutated non-small cell lung cancer (EGFR+ NSCLC): Efficacy of immune checkpoint inhibitors or tyrosine kinase inhibitors combined with platinum-based chemotherapy
Saalfeld, F.C., Möller, J., Michels, S., Grohe, C., Wiesweg, M., Schubart, C., Alt, J., Griesinger, F., Kauffmann-Guerrero, D., Kulhavy, J., Overbeck, T.R., Pelusi, N., Rohde, G., Wesseler, C., Vathiotis, I., Veluswamy, R., Illini, O.M., Rothschild, S.I., Christopoulos, P., Wermke, M.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
2191P Real-world outcomes of patients with malignant pleural mesothelioma (MPM) treated with combination nivolumab and ipilimumab in the first- or later line setting
Schmid, S., Holer, L., Frueh, M., Koster, K-L., Rothschild, S.I., Britschgi, C., Boos, L., Frehner, L., Almeida, S. Cardoso, Metaxas, Y., Mark, M.T., Froesch, P.R., Janthur, W-D., Allemann, A.T., Waibel, C., Mühll-Schill, C. Vonder, Cerciello, F.W.F., Mauti, L.A.
Published in Annals of oncology (01.10.2023)
Published in Annals of oncology (01.10.2023)
Get full text
Journal Article
180P Significant progress in palliative treatment of NSCLC over the last decades: Correlation of treatment milestones with survival in unselected patients
Rothschild, S.I., Nachbur, R., Herzog, N., Passweg, J., Pless, M.
Published in Journal of thoracic oncology (01.04.2018)
Published in Journal of thoracic oncology (01.04.2018)
Get full text
Journal Article
A0164 - Surgical safety and quality of radical cystectomy and pelvic lymph node dissection after neoadjuvant Durvalumab and Cisplatin/Gemcitabine for muscle invasive bladder cancer: Results from the SAKK 06/17 phase II study
Afferi, L., Spahn, M., Hayoz, S., Strebel, R.T., Rothschild, S.I., Seifert, H., Özdemir, B.C., Kiss, B., Maletzki, P., Engeler, D., Wirth, G., Hadaschik, B., Lucca, I., John, H., Sauer, A., Müntener, M., Schneider, M., Musilova, J., Petrausch, U., Cathomas, R.
Published in European urology (01.02.2023)
Published in European urology (01.02.2023)
Get full text
Journal Article
Surgical safety and quality of radical cystectomy and pelvic lymph node dissection after neoadjuvant Durvalumab and Cisplatin/Gemcitabine for muscle invasive bladder cancer: Results from the SAKK 06/17 phase II study
Afferi, L., Spahn, M., Hayoz, S., Strebel, R.T., Rothschild, S.I., Seifert, H., Özdemir, B.C., Kiss, B., Maletzki, P., Engeler, D., Wirth, G., Hadaschik, B., Lucca, I., John, H., Sauer, A., Müntener, M., Schneider, M., Musilova, J., Petrausch, U., Cathomas, R.
Published in European urology (01.02.2023)
Published in European urology (01.02.2023)
Get full text
Journal Article
365P Patterns of progression on first-line osimertinib in patients with EGFR mutation-positive advanced non-small cell lung cancer (NSCLC): A Swiss cohort study
Schuler, A., Huser, J., Schaer, S., Schmid, S., Scherz, A., Gautschi, O., Mauti, L.A., Von Briel, T., Waibel, C., Wannesson De Nicola, L., Pankovics, J., Mark, M.T., Rothschild, S.I., Addeo, A., Janthur, W-D., Siano, M., Britschgi, C., Frueh, M.
Published in Annals of oncology (01.11.2022)
Published in Annals of oncology (01.11.2022)
Get full text
Journal Article
1051P Radiotherapy (RT) and efficacy of immune checkpoint inhibitors (ICI), chemotherapy (CTx) and chemoimmunotherapy (CIT) in patients with non-small cell lung cancer (NSCLC)
Meisel, A., Mark, M.T., Haider, A., Holer, L., Hayoz, S., Gebhard, C., Bengs, S., Treyer, V., Rothschild, S.I., Hochmair, M.J., Gandara, D.R., Cappuzzo, F., Reck, M., Stenner-Liewen, F., von Moos, R.A.F.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
1540P Real-world analysis of outcomes of first-line chemo-immunotherapy in patients with extensive disease small cell lung cancer (ED-SCLC)
Zellweger, N.M., Schmid, S., Bertschinger, M., Waibel, C., Cerciello, F.W.F., Froesch, P.R., Mark, M.T., Bettini, A., Häuptle, P., Blum, V., Litke, T., Helfenstein, F., Frueh, M., Mauti, L.A., Rothschild, S.I.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
LBA65 SAKK 08/14 - IMPROVE Investigation of metformin in patients with metastatic castration-resistant prostate cancer (mCRPC) in combination with enzalutamide vs. enzalutamide alone. A randomized, open label, phase II trial
Rothermundt, C.A., Cathomas, R., Gysel, K., Fischer, N., Mestre, R. Pereira, Hermanns, T., Rothschild, S.I., Mach, N., Mingrone, W., Ciriolo, M., Müller, B., Erdmann, A.A., Schär, C., Mamot, C., Bohanes, P., Omlin, A.G., Bastian, S., Ribi, K., Gillessen, S.
Published in Annals of oncology (01.09.2022)
Published in Annals of oncology (01.09.2022)
Get full text
Journal Article
TCR-beta repertoire convergence and evenness are associated with response to immune checkpoint inhibitors
Jermann, P., Leonards, K., Looney, T., Alborelli, I., Rothschild, S.I., Savic Prince, S., Mertz, K., Zippelius, A., Bubendorf, L.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
LBA16 - TCR-beta repertoire convergence and evenness are associated with response to immune checkpoint inhibitors
Jermann, P., Leonards, K., Looney, T., Alborelli, I., Rothschild, S.I., Savic Prince, S., Mertz, K., Zippelius, A., Bubendorf, L.
Published in Annals of oncology (01.10.2019)
Published in Annals of oncology (01.10.2019)
Get full text
Journal Article
Focusing on cancer patients' intentions to use psychooncological support: A longitudinal, mixed‐methods study
Tondorf, T., Grossert, A., Rothschild, S.I., Koller, M.T., Rochlitz, C., Kiss, A., Schaefert, R., Meinlschmidt, G., Hunziker, S., Zwahlen, D.
Published in Psycho-oncology (Chichester, England) (01.06.2018)
Published in Psycho-oncology (Chichester, England) (01.06.2018)
Get full text
Journal Article
188P SAKK 16/14: Immune profiling of pre-operative biopsies correlates with survival and immune activation in stage IIIA (N2) NSCLC after neoadjuvant immunotherapy
Rothschild, S.I., Sobottka-Brillout, A.B., Tochtermann, G., Trueb, M., Nowak, M., Alborelli, I., Leonards, K., Manzo, M., Keller, E.B., Herzig, P., Schmid, D., Hayoz, S., Chiquet, S., Schneider, M., Pless, M., Jermann, P., Zippelius, A., Prince, S. Savic, Koelzer, V.H.
Published in Journal of thoracic oncology (01.04.2023)
Published in Journal of thoracic oncology (01.04.2023)
Get full text
Journal Article
557P Binimetinib, pemetrexed (Pem) and cisplatin (Cis), followed by maintenance of Binimetinib and Pem in patients with advanced non-small cell lung cancer (NSCLC) and KRAS mutations: The phase Ib SAKK 19/16 trial
Froesch, P.R., Mark, M.T., Rothschild, S.I., Li, Q., Godar, G., Rusterholz, C., Schmid, S., Colombo, I., Metaxas, Y., Thut, H.E., Sessa, C., Gautschi, O., Früh, M.
Published in Annals of oncology (01.09.2020)
Published in Annals of oncology (01.09.2020)
Get full text
Journal Article
EP16.01-018 SAKK 16/14 -Peripheral Immune Cell Populations Inresponse to Neoadjuvant Durvalumab in Patients with Stage IIIA(N2) NSCLC
Schmid, D., Trueb, M., Herzig, P., Gärtner-Pelham, C., Alborelli, I., Leonards, K., Manzo, M., Jermann, P., Prince, S. Savic, Keller, E., Eboulet, E.I., Hayoz, S., Godar, G., Schneider, M., König, D., Pless, M., Zippelius, A., Rothschild, S.I.
Published in Journal of thoracic oncology (01.09.2022)
Published in Journal of thoracic oncology (01.09.2022)
Get full text
Journal Article